Asthma


Breathless Bounty Escape Room

Breathless Bounty Escape Room

Bring a beacon of light to a mysterious treasure discovered by pirates generations ago. Hidden away on the edge of the sea and guided by the desperate plea of your sister, Rose, you must untangle the mysteries of asthma and uncover why this was a breathless bounty.

PLAY THE GAME »

This information is scientific and non-promotional in nature. This educational program was developed by CHEST in collaboration with and sponsored by GSK.

Breathless Bounty Escape Room

Join the Airways Disorders Network

CHEST Networks are specialty-focused communities that provide forums for leadership, education, and advocacy. The Airways Disorders Network educates clinicians about airways disorders, including asthma, COPD, emphysema, bronchiectasis, chronic bronchitis, pediatric medicine, and diseases of large and small airways.

LEARN MORE »

Asthma news and notes

Follow the latest asthma news

ASTHMA AND COPD SECTION

The Emerging Role of Biologic Therapy in Asthma-COPD Overlap
Biologics are an emerging option for select patients with asthma-COPD overlap, particularly those with T2-high inflammatory phenotypes.

PEDIATRIC CHEST MEDICINE SECTION

Advancements in Pediatric Airway Evaluation
Pediatric airway anatomy evaluation continues to evolve with the development of newer technologies such as dynamic volumetric computed tomography.

CHEST PHYSICIAN®

As-Needed Albuterol-Budesonide Found to Benefit Mild Asthma
Study author Craig LaForce, MD, and pulmonologist Kevin Fussell, MD, discuss findings from the BATURA trial and their clinical implications.

BRONCHIECTASIS SECTION

Strengthening More Than Just Airways
Emerging research reveals that nutrition and exercise are two powerful yet underutilized tools in managing bronchiectasis.

PULMONARY PERSPECTIVES®

Hope on the Horizon for Bronchiectasis
Targeted therapies, clinical trial results, and a renewed focus on pulmonary rehabilitation are offering new hope for improved bronchiectasis management.

CHEST PHYSICIAN

COURSE Trial Shows Importance of Biomarker Testing in COPD
While overall the trial was negative, it demonstrated the promise of tezepelumab for patients with baseline blood eosinophil counts ≥ 150 cells/µL.

Build your asthma expertise

CHEST SEEK® Education

Written and peer reviewed by renowned experts in the critical care, pulmonary, and sleep medicine fields, the online CHEST SEEK Library and print publications include case-based questions and detailed rationales to stimulate and challenge your clinical thought process; help you prepare for certification or recertification exams; and allow you to obtain CME credit, MOC points, and CE hours.


CHEST SEEK LIBRARY

Access hundreds of critical care, pulmonary, and sleep medicine questions.

PURCHASE NOW »

Join the community

If you’re not already a CHEST member, become one today for access to additional resources, discounts on educational activities, and networking opportunities.

JOIN NOW »